IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
83 hedge funds and large institutions have $133M invested in IGM Biosciences in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.09% more ownership
Funds ownership: 63.52% → 63.61% (+0.09%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
63% less capital invested
Capital invested by funds: $357M → $133M (-$224M)
Holders
83
Holding in Top 10
1
Calls
$377K
Puts
$224K
Top Buyers
| 1 | +$942K | |
| 2 | +$436K | |
| 3 | +$224K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$184K |
| 5 |
HF
HRT Financial
New York
|
+$132K |
Top Sellers
| 1 | -$3.69M | |
| 2 | -$2.72M | |
| 3 | -$2.11M | |
| 4 |
Goldman Sachs
New York
|
-$1.72M |
| 5 |
CC
Corton Capital
Carrying Place,
Ontario, Canada
|
-$1.1M |